FDA inspection
Prof. Piet P.M.M. Geusens: FDA inspection ending Jan 26, 2018
FDA inspection 1038684 · Voluntary Action Indicated (VAI) · Genk
Key facts
| Inspection ID | 1038684 |
|---|---|
| Firm | Prof. Piet P.M.M. Geusens |
| FEI number | 3004587110 |
| Address | Suite 22, Reumaclinic ; Jaarbeurslaan 21 |
| City | Genk |
| Country | Belgium |
| Fiscal year | 2018 |
| Inspection end date | Jan 26, 2018 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data